Unique Pharmaceuticals Ltd, India   Report issue

For profit Phase 3
Founded: Mumbai India (1972)
Status: No NME R&D (1972)

Organization Overview

First Clinical Trial
2016
NCT02635438
First Marketed Drug
2004
ciprofloxacin (cipro)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Director Medical Services, Unique Pharmacutical Laboratories, India (A Division Of J. B. Chemicals and Pharmacuticals Limited) | UNIQUE PHARM | UNIQUE PHARM LABS